Literature DB >> 33295665

Pediatric teledermatology: A review of the literature.

Alexander M Cartron1, Paola C Aldana1, Amor Khachemoune2,3.   

Abstract

Skin complaints are common among pediatric patients, yet as of 2020, fewer than 400 board-certified pediatric dermatologists currently practice in the United States. Pediatric teledermatology may address barriers to dermatologic care in children, assisting with distant geographic locations and long wait times. A review of the literature was conducted to synthesize important features of teledermatology for pediatric dermatologists. We summarize types of telemedicine platforms, common dermatologic conditions seen by pediatric teledermatologists, diagnostic accuracy and concordance, and guidelines from the American Academy of Dermatology and the American Telemedicine Association regarding teledermatology. This report highlights the utility of pediatric telemedicine in both the outpatient and inpatient dermatology setting to increase access to high-quality dermatologic care.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  pediatric teledermatology; store-and-forward; telemedicine; videoconferencing

Mesh:

Year:  2020        PMID: 33295665     DOI: 10.1111/pde.14479

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  A Glance at the Practice of Pediatric Teledermatology Pre- and Post-COVID-19: Narrative Review.

Authors:  Valencia Long; Nisha Suyien Chandran
Journal:  JMIR Dermatol       Date:  2022-05-17

2.  Evaluating paediatric dermatology telephone clinics during COVID-19 from a dual clinician and patient perspective: a prospective study.

Authors:  A Lowe; S Dawood; A Al-Tayeb; P Hancock; A Pararajasingam; F Ali; R G Goodwin
Journal:  Clin Exp Dermatol       Date:  2021-11-22       Impact factor: 4.481

3.  Disparities in telemedicine use during the COVID-19 pandemic among pediatric dermatology patients.

Authors:  Grace Y Duan; Arlene M Ruiz De Luzuriaga; Liesl M Schroedl; Adena E Rosenblatt
Journal:  Pediatr Dermatol       Date:  2022-03-18       Impact factor: 1.997

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.